Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-03-30-Speech-4-102"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2000-03-30"^^xsd:date2
dcterms:Is Part Of	lp_eu:Vote2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20000330.4.4-102"2
lpv:hasSubsequent	lp_eu:2000-03-30-Speech-4-1032
lpv:speaker	lp:Dana Rosemary Scallon2
lpv:spoken text	"I would like to first congratulate those who have drafted and voted on Directive 98/44/EC which is a step forward in the protection of the human being. Unfortunately, companies have already been developing and patenting cloning techniques. While they state that they support the ban on ‘reproductive cloning’, they have already patented and commercialised human closed cells in order to treat age-related and degenerative diseases. A patent for these techniques has been granted in the UK since August of 1995. While I understand the argument that bona fide cloning experimentation may contribute to scientific advances which would alleviate human suffering, I must point out that there exists a loophole for the totally unacceptable usage of the human embryo at the stage of stem cells, cultures ‘out of their natural environment’. Indeed, this experimentation, under the guise of ‘therapeutic cloning’ is already patented, and the object of ongoing research. In light of this reality, I would ask the Commission to issue a particular reference to the patenting of the human embryo at the stage of stem cells."@en1
lpv:spokenAs	substitute; Committee on Culture, Youth, Education, the Media and Sport (1999-07-21--2002-01-14)3 unknown; Independent (1999-07-20--2004-07-19)3 member; EPP-ED (1999-07-20--2004-07-19)3 member; Committee on Regional Policy, Transport and Tourism (1999-07-21--2002-01-14)3
lpv:unclassifiedMetadata	"Scallon (PPE-DE ),"1 "in writing."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph